Montorsi, F.

prostate cancer prostate cancer biopsy patient study disease treatment dutasteride therapy urology detection level finasteride progression surveillance prostatectomy volume nomogram number trial prostatic 5 aris increase european sc disease gleason placebo prostate volume prostate-speci fic antigen result saturation antigen prostate cancer detection stage group month evidence effect analysis outcome prostate biopsy model epstein psa level prostatic hyperplasia scheme combination psadt disease progression androgen <0.001 recurrence reduction factor criteria diagnosis survival table score validation saturation biopsy surgery biopsy cores combination therapy discussion psa levels prevention cohort alpha-reductase inhibitor transperineal transrectal tumor approach finding university serum hgpin needle